Efficacy and safety of dexmedetomidine as an intrathecal agent: a dose finding clinical study
Anaesthesia, Pain and Intensive Care. 2017; 21 (1): 13-18
en Inglés
| IMEMR
| ID: emr-187457
ABSTRACT
Background and Objectives:
Dexmedetomidine is increasingly being used in regional anesthesia as an adjuvant but there is no consensus on exact minimal and safe dose when used intrathecally. The present study was conducted to evaluate the efficacy of three different doses of dexmedetomidine when given intrathecally as an adjuvant to bupivacaine in patients undergoing lower abdominal surgery
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Inyecciones Espinales
/
Bupivacaína
/
Método Doble Ciego
/
Resultado del Tratamiento
/
Cavidad Abdominal
/
Quimioterapia Combinada
/
Biomarcadores Farmacológicos
Tipo de estudio:
Ensayo Clínico Controlado
Límite:
Adulto
/
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Anaesth. Pain Intensive Care
Año:
2017
Similares
MEDLINE
...
LILACS
LIS